1. Home
  2. VVOS vs RENX Comparison

VVOS vs RENX Comparison

Compare VVOS & RENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.18

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

HOLD

Current Price

$1.77

Market Cap

4.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
RENX
Founded
2016
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.7M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
VVOS
RENX
Price
$0.18
$1.77
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
14.3M
64.2K
Earning Date
04-15-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
N/A
N/A
Revenue
$17,443,000.00
$8,220,449.00
Revenue This Year
$69.66
N/A
Revenue Next Year
$48.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
3860.67
52 Week Low
$0.16
$0.09
52 Week High
$3.70
$3.48

Technical Indicators

Market Signals
Indicator
VVOS
RENX
Relative Strength Index (RSI) 31.62 41.55
Support Level $0.16 $1.68
Resistance Level $0.55 $1.82
Average True Range (ATR) 0.04 0.13
MACD -0.00 -0.03
Stochastic Oscillator 8.21 6.25

Price Performance

Historical Comparison
VVOS
RENX

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

Share on Social Networks: